Christopher Lupfer

3.7k total citations · 1 hit paper
35 papers, 2.9k citations indexed

About

Christopher Lupfer is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Christopher Lupfer has authored 35 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in Christopher Lupfer's work include Inflammasome and immune disorders (14 papers), Influenza Virus Research Studies (10 papers) and interferon and immune responses (8 papers). Christopher Lupfer is often cited by papers focused on Inflammasome and immune disorders (14 papers), Influenza Virus Research Studies (10 papers) and interferon and immune responses (8 papers). Christopher Lupfer collaborates with scholars based in United States, Belgium and Australia. Christopher Lupfer's co-authors include Thirumala‐Devi Kanneganti, Dongin Kim, Peter A. Crawford, Noah J. Planavsky, Kim Nguyen, Tarek M. Fahmy, Monica Bodogai, Seokwon Kang, Arya Biragyn and Yun‐Hee Youm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Christopher Lupfer

33 papers receiving 2.9k citations

Hit Papers

The ketone metabolite β-hydroxybutyrate blocks NLRP3 infl... 2015 2026 2018 2022 2015 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
    2015 1.6k citations Yun‐Hee Youm, Kim Nguyen et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Lupfer United States 18 1.5k 930 862 538 358 35 2.9k
Seokwon Kang United States 10 2.2k 1.5× 977 1.1× 1.1k 1.3× 330 0.6× 354 1.0× 11 3.4k
Calvin Pan United States 32 1.7k 1.1× 728 0.8× 427 0.5× 519 1.0× 215 0.6× 72 3.1k
Heiko Mühl Germany 37 1.4k 1.0× 726 0.8× 1.7k 1.9× 451 0.8× 150 0.4× 104 4.0k
Christian Sina Germany 31 1.5k 1.0× 587 0.6× 851 1.0× 435 0.8× 133 0.4× 110 3.3k
Véronique Bourdeau Canada 24 2.1k 1.4× 922 1.0× 710 0.8× 406 0.8× 195 0.5× 42 4.6k
Senad Divanovic United States 32 709 0.5× 891 1.0× 1.4k 1.6× 1.1k 2.1× 297 0.8× 79 3.6k
W. June Brickey United States 32 3.0k 2.0× 562 0.6× 2.5k 2.9× 932 1.7× 162 0.5× 57 5.2k
C. Henrique Serezani United States 38 1.2k 0.8× 539 0.6× 1.7k 1.9× 683 1.3× 100 0.3× 103 3.9k
Cameron R. Stewart Australia 22 2.4k 1.6× 806 0.9× 1.8k 2.1× 765 1.4× 75 0.2× 40 4.6k
Manuela Cernadas United States 27 2.1k 1.4× 748 0.8× 1.9k 2.1× 1.1k 2.0× 77 0.2× 35 4.7k

Countries citing papers authored by Christopher Lupfer

Since Specialization
Citations

This map shows the geographic impact of Christopher Lupfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lupfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lupfer more than expected).

Fields of papers citing papers by Christopher Lupfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Lupfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lupfer. The network helps show where Christopher Lupfer may publish in the future.

Co-authorship network of co-authors of Christopher Lupfer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Lupfer. A scholar is included among the top collaborators of Christopher Lupfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Lupfer. Christopher Lupfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ickjai & Christopher Lupfer. (2024). Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19. Immunological Reviews. 329(1). e13422–e13422. 1 indexed citations
2.
3.
Lupfer, Christopher, et al.. (2022). The effect of hypochlorous acid on the filtration performance and bacterial decontamination of N95 filtering facemask respirators. American Journal of Infection Control. 51(4). 396–400. 4 indexed citations
4.
Lupfer, Christopher, et al.. (2022). Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(6). 291–295. 3 indexed citations
5.
6.
Lupfer, Christopher, et al.. (2020). What came first, the virus or the egg: Innate immunity during viral coinfections. Immunological Reviews. 297(1). 194–206. 3 indexed citations
7.
Wilson, Michael B., J.M. Williams, Benjamin W. Held, et al.. (2020). Antifungal Norditerpene Oidiolactones from the Fungus Oidiodendron truncatum, a Potential Biocontrol Agent for White-Nose Syndrome in Bats. Journal of Natural Products. 83(2). 344–353. 15 indexed citations
8.
Lupfer, Christopher, et al.. (2020). Pyruvate affects inflammatory responses of macrophages during influenza A virus infection. Virus Research. 286. 198088–198088. 23 indexed citations
9.
McCullers, Jonathan A., et al.. (2019). Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae. PLoS ONE. 14(2). e0212236–e0212236. 29 indexed citations
10.
Lupfer, Christopher, et al.. (2018). Common Differences: The Ability of Inflammasomes to Distinguish Between Self and Pathogen Nucleic Acids During Infection. International review of cell and molecular biology. 344. 139–172. 9 indexed citations
11.
12.
Lupfer, Christopher & Paras Anand. (2016). Integrating Inflammasome Signaling in Sexually Transmitted Infections. Trends in Immunology. 37(10). 703–714. 20 indexed citations
13.
Lupfer, Christopher, Ankit Malik, & Thirumala‐Devi Kanneganti. (2015). Inflammasome control of viral infection. Current Opinion in Virology. 12. 38–46. 117 indexed citations
14.
Youm, Yun‐Hee, Kim Nguyen, Ryan W. Grant, et al.. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nature Medicine. 21(3). 263–269. 1566 indexed citations breakdown →
15.
Lupfer, Christopher, Paul G. Thomas, Paras Anand, et al.. (2013). Receptor interacting protein kinase 2–mediated mitophagy regulates inflammasome activation during virus infection. Nature Immunology. 14(5). 480–488. 318 indexed citations
16.
Lupfer, Christopher & Manoj K. Pastey. (2010). Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132. Virus Research. 149(1). 36–41. 14 indexed citations
17.
Lupfer, Christopher, et al.. (2010). Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1‐Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds. Evidence-based Complementary and Alternative Medicine. 2011(1). 192079–192079. 2 indexed citations
18.
McKenzie, Erica C., Christopher Lupfer, Heidi E. Banse, et al.. (2009). Hypogammaglobulinemia in Racing Alaskan Sled Dogs. Journal of Veterinary Internal Medicine. 24(1). 179–184. 2 indexed citations
19.
Lupfer, Christopher, Kristin M. Patton, & Manoj K. Pastey. (2009). Treatment of Human Respiratory Syncytial Virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade®, PS-341) results in increased inflammation and mortality. Toxicology. 268(1-2). 25–30. 8 indexed citations
20.
Lupfer, Christopher, et al.. (2008). Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers. Archives of Virology. 153(5). 929–937. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seokwon Kang Breakdown of academic impact, for papers by Calvin Pan Breakdown of academic impact, for papers by Heiko Mühl Breakdown of academic impact, for papers by Christian Sina Breakdown of academic impact, for papers by Véronique Bourdeau Breakdown of academic impact, for papers by Senad Divanovic Breakdown of academic impact, for papers by W. June Brickey Breakdown of academic impact, for papers by C. Henrique Serezani Breakdown of academic impact, for papers by Cameron R. Stewart Breakdown of academic impact, for papers by Manuela Cernadas
Rankless by CCL
2026